Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Frontline Mantle Cell Lymphoma Treatment Must Involve Personalized Approach

Nichole Tucker
Published: Wednesday, Aug 07, 2019

Dr. Peter Martin

Peter Martin, MD
First-line therapy for patients with mantle cell lymphoma (MCL) must be administered in an individualized approach based on patient and disease characteristics, according to Peter Martin, MD. 

Peer discussions held during the PER Medical Crossfire: Hematologic Malignancies meeting show several controversies in frontline management, including the difference in therapies that should be used in patients who are younger or older. Physicians do agree, however, that younger patients respond better to intensive therapy than older patients and that BTK inhibition should be used as a second-line therapy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication